181 related articles for article (PubMed ID: 29705850)
1. Psychoneuroimmunology and Natural Killer Cells: The Chromium-Release Whole-Blood Assay.
Fletcher MA; Barnes Z; Broderick G; Klimas NG
Methods Mol Biol; 2018; 1781():209-220. PubMed ID: 29705850
[TBL] [Abstract][Full Text] [Related]
2. Psychoneuroimmunology and natural killer cells: the chromium release whole blood assay.
Fletcher MA; Barnes Z; Broderick G; Klimas NG
Methods Mol Biol; 2012; 934():313-24. PubMed ID: 22933153
[TBL] [Abstract][Full Text] [Related]
3. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
[TBL] [Abstract][Full Text] [Related]
4. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells.
Jang YY; Cho D; Kim SK; Shin DJ; Park MH; Lee JJ; Shin MG; Shin JH; Suh SP; Ryang DW
Ann Clin Lab Sci; 2012; 42(1):42-9. PubMed ID: 22371909
[TBL] [Abstract][Full Text] [Related]
5. Target-induced natural killer cell loss as a measure of NK cell responses.
Warren H
Curr Protoc Immunol; 2012 Apr; Chapter 14():Unit 14.29.1-15. PubMed ID: 22470134
[TBL] [Abstract][Full Text] [Related]
6. Comparing individual NK cell activity in vitro.
Sierich H; Eiermann T
Curr Protoc Immunol; 2013; Chapter 14():Unit 14.32.. PubMed ID: 23392637
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood natural killer (NK) cell function in healthy adults assessed using the target-induced NK loss (TINKL) assay.
Warren HS; Wu F; Horn PL; Pyne DB; West NP; Cripps AW
J Immunol Methods; 2013 Jun; 392(1-2):68-70. PubMed ID: 23567516
[TBL] [Abstract][Full Text] [Related]
8. Effects of maximal exercise on natural killer (NK) cell cytotoxicity and responsiveness to interferon-alpha in the young and old.
Woods JA; Evans JK; Wolters BW; Ceddia MA; McAuley E
J Gerontol A Biol Sci Med Sci; 1998 Nov; 53(6):B430-7. PubMed ID: 9823739
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.
Fletcher MA; Zeng XR; Maher K; Levis S; Hurwitz B; Antoni M; Broderick G; Klimas NG
PLoS One; 2010 May; 5(5):e10817. PubMed ID: 20520837
[TBL] [Abstract][Full Text] [Related]
10. Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays.
Williams BA; Wang XH; Keating A
Cytotherapy; 2010 Nov; 12(7):951-60. PubMed ID: 20230219
[TBL] [Abstract][Full Text] [Related]
11. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Huth TK; Staines D; Marshall-Gradisnik S
J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
[TBL] [Abstract][Full Text] [Related]
12. A highly sensitive whole blood natural killer cell assay.
Bromelow KV; Galea-Lauri J; O'Brien ME; Souberbielle BE
J Immunol Methods; 1998 Aug; 217(1-2):177-84. PubMed ID: 9776587
[TBL] [Abstract][Full Text] [Related]
13. Implementation of the EGFP-K562 flow cytometric NK test: determination of NK cytotoxic activity in healthy elderly volunteers before and after feeding.
Allegra S; Deleine C; Michael-Jubely R; Gryson C; Boirie Y; Kantakamalakul W; Vasson MP
Cytometry A; 2006 Sep; 69(9):992-8. PubMed ID: 16969797
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
15. A novel enhanced green fluorescent protein (EGFP)-K562 flow cytometric method for measuring natural killer (NK) cell cytotoxic activity.
Kantakamalakul W; Jaroenpool J; Pattanapanyasat K
J Immunol Methods; 2003 Jan; 272(1-2):189-97. PubMed ID: 12505723
[TBL] [Abstract][Full Text] [Related]
16. Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay.
Wahlberg BJ; Burholt DR; Kornblith P; Richards TJ; Bruffsky A; Herberman RB; Vujanovic NL
J Immunol Methods; 2001 Jul; 253(1-2):69-81. PubMed ID: 11384670
[TBL] [Abstract][Full Text] [Related]
17. Target-induced natural killer cell loss as a measure of NK cell responses.
Warren H
Curr Protoc Immunol; 2013; Chapter 14():Unit 14.29.1-21. PubMed ID: 23564684
[TBL] [Abstract][Full Text] [Related]
18. The analysis of natural killer cell activity by flow cytometry.
Racz T; Sacks P; Van NT; Taylor DL; Young G; Bugis S; Savage HE; Schantz SP
Arch Otolaryngol Head Neck Surg; 1990 Apr; 116(4):440-6. PubMed ID: 1690553
[TBL] [Abstract][Full Text] [Related]
19. The use of non-radioactive chromium as an alternative to 51Cr in NK assay.
Borella P; Bargellini A; Salvioli S; Medici CI; Cossarizza A
J Immunol Methods; 1995 Oct; 186(1):101-10. PubMed ID: 7561139
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometry-based assay for determination of teleost cytotoxic cell lysis of target cells.
Oumouna M; Jaso-Friedmann L; Evans DL
Cytometry; 2001 Dec; 45(4):259-66. PubMed ID: 11746095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
